Clinical significance of homocysteine in elderly hospitalized patients

Metabolism: Clinical and Experimental

Volumn 55, Issue 5, 2006, Pages 620-627

  Rodríguez, José Juan Viña ^a   Santolaria, Francisco ^a   Martínez Riera, Antonio ^a   González Reimers, Emilio ^a   Prieto, María José de la Vega ^a   Valls, María Remedios Alemán ^a   Gaspar, Melchor Rodríguez ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; COBALAMIN; CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; TRIACYLGLYCEROL;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ACUTE DISEASE; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; COGNITIVE DEFECT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; EMPIRICISM; FEMALE; FOLIC ACID BLOOD LEVEL; HEALTH STATUS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOALBUMINEMIA; INFLAMMATION; KAPLAN MEIER METHOD; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEPSIS; SURVIVAL TIME; TELEMEDICINE; VASCULAR DISEASE; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CREATININE; FEMALE; HEMOGLOBINS; HOMOCYSTEINE; HUMANS; LYMPHOCYTE COUNT; MALE; NEUTROPHILS; NUTRITIONAL STATUS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SERUM ALBUMIN; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TRIAZOLES; VITAMIN B 12;

EID: 33646073775     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.12.009     Document Type: Article

References (42)

1. Malinow M.R., Bostom A.G., and Krauss R.M. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99 (1999) 178-182
2. Selhub J., Jacques P.F., Bostom A.G., et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332 (1995) 286-291
3. Bautista L.E., Arenas I.A., Penuela A., et al. Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol 55 (2002) 882-887
4. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 (2002) 2015-2022
5. den Heijer M., Rosendaal F.R., Blom H.J., et al. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 80 (1998) 874-877
6. Vasan R.S., Beiser A., D'Agostino R.B., et al. Related plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA 289 (2003) 1251-1257
7. Schofield R.S., Wessel T.R., Walker T.C., et al. Hyperhomocysteinemia in patients with heart failure referred for cardiac transplantation: preliminary observations. Clin Cardiol 26 (2003) 407-410
8. Cook R.C., Tupper J.K., Parker S., et al. Effect of immunosuppressive therapy, serum creatinine, and time after transplant on plasma total homocysteine in patients following heart transplantation. J Heart Lung Transplant 18 (1999) 420-424
9. Seshadri S., Beiser A., Selhub J., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346 (2002) 476-483
10. Ravaglia G., Forti P., Maioli F., et al. Homocysteine and cognitive performance in healthy elderly subjects. Arch Gerontol Geriatr Suppl 9 (2004) 349-357
11. Miller J.W., Green R., Ramos M.I., et al. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 78 (2003) 441-447
12. Ventura P., Panini R., Verlato C., et al. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects. Metabolism 50 (2001) 1466-1471
13. Marengoni A., Cossi S., De Martinis M., et al. Homocysteine and disability in hospitalized geriatric patients. Metabolism 53 (2004) 1016-1020
14. Bostom A.G., Silbershatz H., Rosenberg I.H., et al. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159 (1999) 1077-1080
15. Vollset S.E., Refsum H., Tverdal A., et al. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr 74 (2001) 130-136
16. Kark J.D., Selhub J., Adler B., et al. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med 131 (1999) 321-330
17. Sirrs S., Duncan L., Djurdjev O., et al. Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship. Nephrol Dial Transplant 14 (1999) 738-743
18. Suliman M.E., Qureshi A.R., Barany P., et al. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int 57 (2000) 1727-1735
19. Suliman M.E., Stenvinkel P., Qureshi A.R., et al. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy. Am J Kidney Dis 44 (2004) 455-465
20. Kalantar-Zadeh K., Block G., Humphreys M.H., et al. A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 15 (2004) 442-453
21. Kalantar-Zadeh K., Ikizler T.A., Block G., et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42 (2003) 864-881
22. Sengupta S., Wehbe Ch., Majors A.K., et al. Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation. J Biol Chem 276 (2001) 46896-46904
23. Senni M., Tribouilloy Ch.M., Rodeheffer R.J., et al. Congestive Heart Failure in the Community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 98 (1998) 2282-2289
24. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 23 (1975) 433-441
25. Martínez J., Dueñas R., Onís M.C., et al. Adaptación y validación al castellano del cuestionario de Pfeiffer (SPMSQ) para detectar la existencia de deterioro cognitivo en personas mayores de 65 años. Med Clin (Barc) 117 (2001) 129-134
26. Blackburn G.L., Bistrian B.R., Maini B.S., et al. Nutritional and metabolic assessment of the hospitalized patient. JPEN 1 (1977) 11-22
27. González-Hermoso F., Porta R., and Herrero A. Resultados del estudio antropométrico de la población canaria adulta. Nutr Hosp 5 (1990) 238-247
28. Hernández-Plasencia D., Santolaria F., Hernández-García M., et al. Subjective nutritional assessment and short term prognosis. J Nutr Med 2 (1991) 151-162
29. Tormo A., Santolaria F., González-Reimers E., et al. Short-term prognostic value of subjective nutritional assessment in general medical patients. J Nutr Med 4 (1994) 287-295
30. Ueland P.M., Refsum H., Stabler S.P., et al. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39 (1993) 1764-1779
31. Henriquez-Sanchez P., Diaz-Romero C., Rodriguez-Rodriguez E., et al. Biochemical assessment of nutritional status in the Canary Islands population (1998). Arch Latinoam Nutr 50 Suppl 1 (2000) 43-54
32. Vychytil A., Fodinger M., Wolfl G., et al. Major determinants of hyperhomocysteinemia in peritoneal dialysis patients. Kidney Int 53 (1998) 1775-1782
33. Dierkes J., Jeckel A., Ambrosch A., et al. Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study. Metabolism 50 (2001) 640-645
34. 12 status on plasma homocysteine in Saudis. Saudi Med J 23 (2002) 868-959
35. Salles-Montaudon N., Parrot F., Balas D., et al. Prevalence and mechanisms of hyperhomocysteinemia in elderly hospitalized patients. J Nutr Health Aging 7 (2003) 111-116
36. Ingenbleek Y., Hardillier E., and Jung L. Subclinical protein malnutrition is a determinant of hyperhomocysteinemia. Nutrition 18 (2002) 40-46
37. Lind P., Hedblad B., Hultberg B., et al. Risk of myocardial infarction in relation to plasma levels of homocysteine and inflammation-sensitive proteins: a long-term nested case-control study. Angiology 54 (2003) 401-410
38. Suliman M.E., Stenvinkel P., Barany P., et al. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. Am J Kidney Dis 41 (2003) S89-S95
39. Kalantar-Zadeh K., Block G., Humphreys M.H., et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63 (2003) 793-808
40. Kalantar-Zadeh K., Block G., Horwich T., et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43 (2004) 1439-1444
41. Curtis J.P., Selter J.G., Wang Y., et al. The obesity paradox. Body mass index and outcomes in patients with heart failure. Arch Intern Med 165 (2005) 55-61
42. Kopple J.D. The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. Am J Clin Nutr 81 (2005) 1257-1266